Pfizer Loses Bid To Stop Rebate Disclosures To Lawmakers
Pfizer Inc. fell short of proving the disclosure of its drug pricing and rebate information to two state legislators by the Texas Health and Human Services Commission was a violation of...To view the full article, register now.
Already a subscriber? Click here to view full article